Report cover image

Cell Surface Markers Detection Market

Published Aug 20, 2025
Length 174 Pages
SKU # CMI20399658

Description

Cell surface markers detection refers to separation and identification of target cells using analytical methods and processes, such as flow cytometry. Cell surface marker analysis through the usage of technologies, such as flow cytometry, is expected to simplify disease analysis, sample separation, disease diagnosis, and subsequent treatment determination.

Market Dynamics

Rise in use of cell surface markers in disease diagnostics, rise in prevalence of cancer, increasing adoption of flow cytometry in stem cell research, increasing demand for precision medicine, and technological advances related to increased throughput and automation are major factors expected to drive growth of the global cell surface markers detection market.

For instance, in April 2022, Sysmex Europe, a provider of automated workflow solutions in the disciplines of hematology, urinalysis, and hemostasis, launched Flow Cytometer XF-1600 which has received CE marking, indicating its compliance with the European IVD Regulation and IVD use; establishing a complete solution for flow cytometry laboratories to help them automate and optimize their workflow for a new level of efficiency.

Key features of the study
  • This report provides in-depth analysis of the global cell surface markers detection market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cell surface markers detection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cell surface markers detection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers detection market.
Market Segmentation
  • Global Cell Surface Markers Detection Market, By Product
  • Flow Cytometry
  • Hematology Analysers
  • Cell Imaging Systems
  • Reagents and Kits
  • Other Products
  • Global Cell Surface Markers Detection Market, By Application
  • Disease Diagnosis and Identification
  • Drug Discovery
  • Other – Research and Academia Applications
  • Global Cell Surface Markers Detection Market, By Geography
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Grifols SA
  • Abbott Laboratories
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • Nexcelom Bioscience
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio Rad Laboratories Inc.
  • Becton, Dickinson and Company (BD)
  • Qiagen NV
  • Diasorin SpA (Luminex Corporation)
  • Danaher Corporation (Beckman Coulter Inc.)
  • IVD Medical Holding Limited (Immucor Inc.)

Table of Contents

174 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product
Market Snapshot, By Application
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rise in use of cell surface markers disease diagnostics
High cost of instruments and dearth of skilled professionals
Rise in prevalence of cancer worldwide
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Cell Surface Markers Detection Market, By Product, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Flow Cytometry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hematology Analysers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cell Imaging Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Reagents and Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Cell Surface Markers Detection Market, By Application, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Disease Diagnosis and Identification
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Drug Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other – Research and Academia Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Cell Surface Markers Detection Market, By Geography, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
GCC Countries
Israel
Rest of Middle East
South Africa
North Africa
Central Africa
7. Competitive Landscape
Grifols SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sysmex Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Agilent Technologies Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Nexcelom Bioscience
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Siemens Healthineers
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Nihon Kohden Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bio Rad Laboratories Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Becton, Dickinson and Company (BD)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Qiagen NV
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Diasorin SpA (Luminex Corporation)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Danaher Corporation (Beckman Coulter Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
IVD Medical Holding Limited (Immucor Inc.)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.